The market is clearly expecting a big downgrade for ORA, the large packaging company.

The AGM pointed to the slowing outlook in North America and inflationary pressures in Australia (and elsewhere, really) but hung on to guidance. Is it priced cheap enough for downgrade risk?

Amcor today also had a modest negative flavour to the outlook (although they are in a much stronger position, so we aren’t worried overmuch).

But for ORA it is difficult.


The market is clearly expecting the UK economy to collapse outright, given the spread between VUK (the old Clydesdale bank) and the earnings trajectory.

Betting on a housing implosion (and rising BDDs) is an attractive trade but challenging to pull off.

The tailwinds are clear: rising net interest margins, thanks to higher interest rates. But the threat of insolvencies outweighs the benefits, in the market’s mind.

Compare the P/Sales ratio for VUK to every other Aussie bank. There is a sizeable discount. Not for the faint of heart.


It just continues to amaze me that all LLC need to do is not haemorrhage cash (read, execute well on work already done), and the re-rate can/could be enormous. A most frustrating hold.


GEM is enjoying what might be the first modest forecast EPS upgrades in a while. They were net beneficiaries of the budget, but the main thing is the lack of crushing respiratory viruses and torrential flooding.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.